EXCEED THE SPACE PROVIDED. The biological functions of the aryl hydrocarbon receptor (AhR) are normallyattributed to its functioning as a ligand-activated transcription factor. However, recent studies suggest that the AhR may have ligand- independent functions. Studies with murine hepatoma cells engineered to have different AhR contents show a direct correlation between AhR content and susceptibility to apoptosis induced by ceramide, but not other agents. Recent studies have shown that ceramide causes lysosome disruption, cleavage of cytosolic Bid, release of cytochrome c, and activation of the 'mitochondria!'apoptotic pathway in AhR-containing cells. The effects of ceramide could be duplicated by the targeted disruption of lysosomes with photodynamic therapy (PDT). Because PDT and ceramide disrupt the lysosomes of AhR-deficient cells, but do not cause Bid cleavage we hypothesize that 1) lysosome disruption triggers the 'mitochondria!' apoptotic pathway via lysosomal protease cleavage of Bid, and 2) the AhR modulates processes involved in Bid cleavage. In this application we propose to use Bid null and AhR null cells to determine if activation of the 'mitochondria!' apoptotic pathway by ceramide/PDTis dependent upon 1) Bid and 2) AhR content, respectively. 3) We will determine if the inability of our AhR-deficient cell lines to cleave Bid reflects the absence of a lysosomal Bid cleavage activity, or the presence of cytosolic protein(s) that inhibit this activity. 4) We will attempt to identify the lysosomal activity responsible for Bid cleavage by conventional purification techniques, selective pharmacological inhibition, or a proteomic approach. 5) Transfection of mutated forms of the AhR into AhR-deficient cells will be used to determine the regions/functions (e.g., DNA and ligand-binding, heterodimerization, transactivation, etc.) of the AhR important in the modulation of Bid cleavage/ceramide- induced apoptosis. Lastly, 6) a series of 'oxidative stressors' will be tested to determine if oxidant-induced activation of the 'mitochondria!' apoptotic pathway is a downstream consequence of lysosome disruption and Bid cleavage. These studies will provide a mechanism linking lysosome disruption and apoptosis, and characterize a novel AhR function. The concept that lysosome disruption can trigger apoptosis, in addition to necrosis, is relevant to the mechanism of action of many toxicants, and health-related areas such as neuro and pulmonary toxicology, chemo-and phototherapy, stroke research, and reperfusion induced injury. PERFORMANCE SITE ========================================Section End===========================================

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Project (R01)
Project #
5R01ES009392-07
Application #
6856536
Study Section
Alcohol and Toxicology Subcommittee 4 (ALTX)
Program Officer
Heindel, Jerrold
Project Start
1999-02-01
Project End
2007-02-28
Budget Start
2005-03-01
Budget End
2007-02-28
Support Year
7
Fiscal Year
2005
Total Cost
$298,000
Indirect Cost
Name
Wayne State University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
001962224
City
Detroit
State
MI
Country
United States
Zip Code
48202
Reiners Jr, John J; Kleinman, Miriam; Kessel, David et al. (2011) Nonesterified cholesterol content of lysosomes modulates susceptibility to oxidant-induced permeabilization. Free Radic Biol Med 50:281-94
Kessel, David; Vicente, M Graca H; Reiners Jr, John J (2006) Initiation of apoptosis and autophagy by photodynamic therapy. Lasers Surg Med 38:482-8
Caruso, Joseph A; Mathieu, Patricia A; Joiakim, Aby et al. (2006) Aryl hydrocarbon receptor modulation of tumor necrosis factor-alpha-induced apoptosis and lysosomal disruption in a hepatoma model that is caspase-8-independent. J Biol Chem 281:10954-67
Caruso, Joseph A; Reiners Jr, John J (2006) Proteolysis of HIP during apoptosis occurs within a region similar to the BID loop. Apoptosis 11:1877-85
Reiners Jr, John J; Kessel, David (2005) Susceptibility of myelomonocytic leukemia U937 cells to the induction of apoptosis by the non-peptidic Bcl-2 ligand HA14-1 is cell cycle phase-dependent. Cancer Lett 221:153-63
Caruso, Joseph A; Mathieu, Patricia A; Reiners Jr, John J (2005) Sphingomyelins suppress the targeted disruption of lysosomes/endosomes by the photosensitizer NPe6 during photodynamic therapy. Biochem J 392:325-34
Kessel, D; Castelli, M; Reiners, J J (2005) Ruthenium red-mediated suppression of Bcl-2 loss and Ca(2+) release initiated by photodamage to the endoplasmic reticulum: scavenging of reactive oxygen species. Cell Death Differ 12:502-11
Joiakim, Aby; Mathieu, Patricia A; Elliott, Althea A et al. (2004) Superinduction of CYP1A1 in MCF10A cultures by cycloheximide, anisomycin, and puromycin: a process independent of effects on protein translation and unrelated to suppression of aryl hydrocarbon receptor proteolysis by the proteasome. Mol Pharmacol 66:936-47
Castelli, M; Reiners, J J; Kessel, D (2004) A mechanism for the proapoptotic activity of ursodeoxycholic acid: effects on Bcl-2 conformation. Cell Death Differ 11:906-14
Caruso, Joseph A; Mathieu, Patricia A; Joiakim, Aby et al. (2004) Differential susceptibilities of murine hepatoma 1c1c7 and Tao cells to the lysosomal photosensitizer NPe6: influence of aryl hydrocarbon receptor on lysosomal fragility and protease contents. Mol Pharmacol 65:1016-28

Showing the most recent 10 out of 19 publications